BridgeBio management to participate in September investor conferences
BridgeBio Pharma, Inc. said members of its management team will participate in September investor conferences.
PALO ALTO, Calif., Sept.
01, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc.
NASDAQ:BBIO (“BridgeBio” or the “Company”), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for genetic conditions, today announced that members of its management team will parti…